• Latest Posts

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA 

Sponsored by 23 Nov 2023

How tiger teams are transforming the life sciences startup landscape

M&As: what’s up with the ADC buying spree?

Podcast 17 Nov 2023

How can life-saving vaccines be more affordable?

In Depth 15 Nov 2023

Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy

ADVERTISEMENT
Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

Podcast 15 Sep 2023

Beyond Biotech podcast 63 – Fighting cancer with STRIs

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

ADVERTISEMENT